Related people
Irina Rebin
Irina is a member of the Practice Area Patents Technology and Life Sciences and the Life Science & Healthcare Industry Group. She advises national and international pharmaceutical and medical device companies on regulatory aspects and industry-specific agreements.
Show full CV
Hide full CV
More
Less
More
Less
Career
| Since 2020 | Associate, Taylor Wessing |
| 2020 | Lawyer at a public body in the health care sector in Munich |
| 2017 – 2019 | Legal clerkship, Higher Regional Court of Munich |
| 2015 – 2018 | Research and teaching Assistant, department of civil law and medical law, Ludwigs Maximilians University, Munich |
Education
| 2020 | Admitted as a lawyer, Munich |
| 2019 | Second state examination, Munich |
| 2014 – 2018 | PhD programme at Ludwig Maximilians University in Munich |
| 2013 | First state examination, Goettingen |
Publications
| § 2 ProdHaftG, comment in: Gsell/Krüger/Lorenz/Reymann: Beck-OGK regarding civil law |
Additional languages
| English |
Latest news & insights
Commercial & consumer contracts
Click here to find out more
The Long and Winding Road: (Some) EU and FDA Issues to Consider with Clinical Trials and Clinical Trial Agreements
21 September 2023
In-depth analysis
by Dr. Manja Epping and Irina Rebin
Life sciences & healthcare
Click here to find out more
Clinical trials on medicinal products for human use under the new EU Clinical Trials Regulation No. 536/2014 (“CTR”)
21 September 2022
In-depth analysis
by Dr. Manja Epping and Irina Rebin
Life sciences & healthcare
Click here to find out more
In-vitro Diagnostic Medical Devices under the new Regulation (EU) 2017/746
20 September 2022
In-depth analysis
by Dr. Manja Epping and Irina Rebin
Corporate/M&A & capital markets
Click here to find out more
Taylor Wessing advises Azenta Life Sciences on the acquisition of the Barkey Group
17 June 2022
by multiple authors
